{"status":"success","data":{"title":"Clostridium Difficile Infection","slug":"cdiff","tags":null,"collection":["infectious disease"],"content":"\n# Clostridium Difficile Infection (CDI)\n\n**TREATMENT**\n\n<table>\n<colgroup>\n<col width=\"50%\" />\n<col width=\"50%\" />\n</colgroup>\n<thead>\n<tr class=\"header\">\n<th><strong>Clinical category</strong></th>\n<th><strong>Therapy</strong></th>\n</tr>\n</thead>\n<tbody>\n<tr class=\"odd\">\n<td>1st episode, <br />\nmild-mod severity</td>\n<td><strong><span class=\"drug\">Metronidazole</span></strong> 500 mg PO TID x 10-14 days</td>\n</tr>\n<tr class=\"even\">\n<td>1st episode, severe</td>\n<td><strong><span class=\"drug\">Vancomycin</span></strong> 125 mg PO QID x 10-14 days</td>\n</tr>\n<tr class=\"odd\">\n<td>1st episode, severe,complicated</td>\n<td><strong><span class=\"drug\">Vancomycin</span></strong> 500 mg QID PO/NG (PR if ileus) PLUS<br />\n\n<p><strong><span class=\"drug\">Metronidazole</span></strong> 500 mg IV q8h</p></td>\n</tr>\n<tr class=\"even\">\n<td>First recurrence</td>\n<td>Same as for 1st episode (b/c minimal resistance<br />\nrate)</td>\n</tr>\n<tr class=\"odd\">\n<td>Second and more recurrences</td>\n<td><strong><span class=\"drug\">Vancomycin</span></strong> PO in tapered or pulsed regimen.<br />\n\n<p><strong>Avoid metronidazole</strong> overuse b/c of neurotoxicity.</p></td>\n</tr>\n</tbody>\n</table>\n\n## Background\n\n**Definition of *Clostridium difficile* infection (CDI)**\n\n-   Presence of diarrhea (3 unformed stools in ≤24 hours)\n-   Stool test positive for *C. difficile* or its toxins, or colonoscopic findings of pseudomembranous colitis\n\n**Epidemiology**\n-   Accounts for 20-30% of all antibiotic-associated diarrhea\n-   Most common cause of infectious diarrhea in healthcare settings\n\n**Transmission**\n-   Fecal-oral route\n-   Median time from exposure to C. difficile to diarrhea symptoms = 2-3 days\n\n**Risk factors to develop CDI**\nAge ≥ 65 years\nDuration of hospitalization\nExposure to antibiotics (almost every Abx has been assoc with CDI – not just clindamycin)\n-   96% have received abx within 14 days before diarrhea onset \n\nCancer chemotherapy\nHIV\nGI surgery or manipulation of GI tract (i.e. tube feeding)\n**Clinical presentation**\n-   Diarrhea may have mucous or occult blood\n\n**Recurrence rates**\n-   20% (typically within 4 weeks), despite metronidazole or vanco tx. ([Kelly et al., NEJM, 2008](https://www.ncbi.nlm.nih.gov/pubmed/?term=18971494))\n\n\n## Complications\n\n-   Bowel perforation\n-   Dehydration\n-   Electrolyte imbalance \n-   Hypoalbuminemia\n-   Hypotension\n-   Renal failure\n-   SIRS, sepsis, death\n-   Toxic megacolon\n\n## References\n\n-   [Cohen SH, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by SHEA and IDSA. Infect Control Hosp Epidemiol. 2010; 31(5):431-55.](https://www.ncbi.nlm.nih.gov/pubmed/?term=20307191)\n-   [Kelly CP, LaMont JT.Clostridium difficile--more difficult than ever.N Engl J Med. 2008 Oct 30;359(18):1932-40. doi: 10.1056/NEJMra0707500.](https://www.ncbi.nlm.nih.gov/pubmed/?term=18971494)\n"}}